• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HER2/c-erbB-2的磷酸化位点:在细胞生长和疾病中的作用

Phosphorylation sites of HER2/c-erbB-2: role in cell growth and in disease.

作者信息

Khurshid Rukhshan, Saleem Mahjabeen, Akhthar Muhammad Saleem

机构信息

Department of Biochemistry, Fatima Jinnah Medical College, Lahore, Pakistan.

Institute of Biochemistry and Biotechnology, University of the Punjab, Lahore, Pakistan.

出版信息

Acta Biochim Pol. 2014;61(4):699-703. Epub 2014 Nov 14.

PMID:25399009
Abstract

The protein kinase c-erbB-2 belongs to the family of receptor tyrosine kinase and is involved in oncogenesis. The present study predicts different phosphorylation sites of HER2/c-erbB-2 which are important in preventing or developing cancer, especially breast cancer. Sequence homology showed highest homology (77%) with epidermal growth factor receptor kinase domain. According to PROSITE search result, active sites of c-erbB-2 are N-lobe (glycine rich phosphate binding loop). Catalytic loop with presumptive catalytically active of Asp108 is phosphorylated by tyrosine protein kinase. A-loop, activation loop, becomes phosphorylated and activates the substrate binding. The study strengthens our knowledge regarding HER2 signaling by the detection of uncharacterized signaling proteins, establishing phosphorylation of an activation loop and helps us to make assumptions about the role of such previously unidentified proteins. On the basis of importance of HER2 in breast cancer as well as in other diseases, this study provides fruitful information for designing new therapeutic strategies.

摘要

蛋白激酶c-erbB-2属于受体酪氨酸激酶家族,参与肿瘤发生。本研究预测了HER2/c-erbB-2的不同磷酸化位点,这些位点在预防或引发癌症尤其是乳腺癌方面具有重要意义。序列同源性显示,其与表皮生长因子受体激酶结构域的同源性最高(77%)。根据PROSITE搜索结果,c-erbB-2的活性位点是N-叶(富含甘氨酸的磷酸结合环)。具有假定催化活性的Asp108的催化环被酪氨酸蛋白激酶磷酸化。A环即激活环发生磷酸化并激活底物结合。该研究通过检测未表征的信号蛋白,证实激活环的磷酸化,加强了我们对HER2信号传导的认识,并帮助我们对这类先前未鉴定蛋白的作用进行推测。基于HER2在乳腺癌以及其他疾病中的重要性,本研究为设计新的治疗策略提供了丰富的信息。

相似文献

1
Phosphorylation sites of HER2/c-erbB-2: role in cell growth and in disease.HER2/c-erbB-2的磷酸化位点:在细胞生长和疾病中的作用
Acta Biochim Pol. 2014;61(4):699-703. Epub 2014 Nov 14.
2
Epidermal growth factor receptor coexpression modulates susceptibility to Herceptin in HER2/neu overexpressing breast cancer cells via specific erbB-receptor interaction and activation.表皮生长因子受体共表达通过特定的erbB受体相互作用和激活来调节HER2/neu过表达乳腺癌细胞对赫赛汀的敏感性。
Exp Cell Res. 2005 Apr 1;304(2):604-19. doi: 10.1016/j.yexcr.2004.12.008. Epub 2005 Jan 21.
3
Atomistic insights into regulatory mechanisms of the HER2 tyrosine kinase domain: a molecular dynamics study.关于HER2酪氨酸激酶结构域调控机制的原子水平见解:一项分子动力学研究
Biophys J. 2009 Mar 18;96(6):2321-34. doi: 10.1016/j.bpj.2008.12.3912.
4
Epidermal growth factor receptor (HER1) tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2/neu (erbB2)-overexpressing breast cancer cells in vitro and in vivo.表皮生长因子受体(HER1)酪氨酸激酶抑制剂ZD1839(易瑞沙)在体外和体内均可抑制HER2/neu(erbB2)过表达的乳腺癌细胞。
Cancer Res. 2001 Dec 15;61(24):8887-95.
5
Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.催乳素调节人T47D乳腺癌细胞中表皮生长因子受体的磷酸化、信号传导和运输。
Oncogene. 2006 Dec 7;25(58):7565-76. doi: 10.1038/sj.onc.1209740. Epub 2006 Jun 19.
6
Breast cancer expressing the activated HER2/neu is sensitive to gefitinib in vitro and in vivo and acquires resistance through a novel point mutation in the HER2/neu.表达激活型HER2/neu的乳腺癌在体外和体内对吉非替尼敏感,并通过HER2/neu中的一种新的点突变获得耐药性。
Cancer Res. 2007 Jul 15;67(14):6825-43. doi: 10.1158/0008-5472.CAN-07-0765.
7
The ErbB/HER receptor protein-tyrosine kinases and cancer.表皮生长因子受体(ErbB/HER)蛋白酪氨酸激酶与癌症
Biochem Biophys Res Commun. 2004 Jun 18;319(1):1-11. doi: 10.1016/j.bbrc.2004.04.150.
8
The oncogenic ErbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin.致癌性表皮生长因子受体2/表皮生长因子受体3异二聚体是表皮生长因子和β细胞素的替代受体。
Oncogene. 1998 Mar 12;16(10):1249-58. doi: 10.1038/sj.onc.1201642.
9
Comparison of the biochemical and kinetic properties of the type 1 receptor tyrosine kinase intracellular domains. Demonstration of differential sensitivity to kinase inhibitors.1型受体酪氨酸激酶细胞内结构域的生化和动力学特性比较。对激酶抑制剂的差异敏感性证明。
J Biol Chem. 2002 Jan 11;277(2):1576-85. doi: 10.1074/jbc.M105907200. Epub 2001 Nov 5.
10
Insulin-like growth factor and epidermal growth factor independence in human mammary carcinoma cells with c-erbB-2 gene amplification and progressively elevated levels of tyrosine-phosphorylated p185erbB-2.在具有c-erbB-2基因扩增且酪氨酸磷酸化的p185erbB-2水平逐渐升高的人乳腺癌细胞中胰岛素样生长因子和表皮生长因子非依赖性
Mol Carcinog. 1996 Mar;15(3):227-38. doi: 10.1002/(SICI)1098-2744(199603)15:3<227::AID-MC8>3.0.CO;2-E.

引用本文的文献

1
Non-phosphorylated Tyr-1248 form of human epidermal growth factor receptor 2 (HER2) predicts resistance to trastuzumab therapy and poor disease-free survival of HER2-positive breast cancer patients.非磷酸化的人表皮生长因子受体 2(HER2)Tyr-1248 形式可预测曲妥珠单抗治疗耐药和 HER2 阳性乳腺癌患者无病生存期不良。
Croat Med J. 2022 Apr 30;63(2):126-140. doi: 10.3325/cmj.2022.63.126.
2
Structural and dynamic characterization of the C-terminal tail of ErbB2: Disordered but not random.ErbB2 羧基末端尾部的结构和动力学特征:无规则但非随机。
Biophys J. 2021 May 18;120(10):1869-1882. doi: 10.1016/j.bpj.2021.03.005. Epub 2021 Mar 17.